An international team of researchers conducted a trial as part of the multinational EDITION 1 study, comparing the efficacy and safety of new insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in people with type 2 diabetes on basal insulin (≥42 units/day) plus mealtime insulin.
DiabetesInControl – U300 Insulin Glargine Produces Lower Rates of Night Time Hypoglycemia
Posted in Glucose & Insulin Medical Research